Habteyes Hailu Tola - Epidemiology

Author Information

Habteyes Hailu Tola is an esteemed researcher affiliated with the Department of Epidemiology and Biostatistics at the School of Public Health, Tehran University Medical, Tehran, Iran, and the Tuberculosis/HIV Research Directorate at the Ethiopian Public Health Institute in Addis Ababa, Ethiopia. His work primarily focuses on epidemiology, with significant contributions to understanding and managing infectious diseases such as tuberculosis and COVID-19.

Research Contributions

Habteyes Hailu Tola has made substantial contributions to the field of epidemiology, particularly in the study of infectious diseases like COVID-19 and tuberculosis. In 2021 alone, he authored multiple papers covering crucial topics such as the case fatality rate of COVID-19, the outcomes and predictors of multidrug-resistant tuberculosis treatment in Ethiopia, and the association of mycobacterial lineages with drug resistance. His research also delves into the diagnostic accuracy of tuberculosis assays and the incidence of hepatotoxicity in people living with HIV undergoing antiretroviral therapy. His work is instrumental in shaping public health policies and improving treatment outcomes in low-resource settings.

Aliases

Habteyes Hailu Tola is also known by several aliases including Habteyes H. Tola and Habteyes Tola.

Publication and Citation Metrics

Metric	Value
Citation Count	599
H-index	11
Paper Count	38

Publications:

Case fatality rate of COVID-19: a systematic review and meta-analysis

DOI: 10.15167/2421-4248/jpmh2021.62.2.1627

Year: 2021

National treatment outcome and predictors of death and treatment failure in multidrug-resistant tuberculosis in Ethiopia: a 10-year retrospective cohort study

DOI: 10.1136/bmjopen-2020-040862

Year: 2021

Mycobacterial Lineages Associated with Drug Resistance in Patients with Extrapulmonary Tuberculosis in Addis Ababa, Ethiopia

DOI: 10.1155/2021/5239529

Year: 2021

Incidence of Hepatotoxicity and Factors Associated During Highly Active Antiretroviral Therapy in People Living with HIV in Ethiopia: A Prospective Cohort Study

DOI: 10.2147/HIV.S283076

Year: 2021

Drug resistance and its risk factors among extrapulmonary tuberculosis in Ethiopia: A systematic review and meta-analysis

DOI: 10.1371/journal.pone.0258295

Year: 2021

Diagnostic accuracy of Truenat Tuberculosis and Rifampicin-Resistance assays in Addis Ababa, Ethiopia

DOI: 10.1371/journal.pone.0261084

Year: 2021

Low enrollment and high treatment success in children with drug-resistant tuberculosis in Ethiopia: A ten years national retrospective cohort study

DOI: 10.1371/journal.pone.0229284

Year: 2020

Multidrug resistant tuberculosis treatment outcome in children in developing and developed countries: A systematic review and meta-analysis.

DOI: 10.1016/j.ijid.2020.03.064

Year: 2020

Molecular characterization and drug resistance patterns of Mycobacterium tuberculosis complex in extrapulmonary tuberculosis patients in Addis Ababa, Ethiopia

DOI: 10.1371/journal.pone.0243493

Year: 2020

Risk communication during novel corona-virus disease 2019 pandemic in low health service coverage setup: The case of Ethiopia

DOI: 10.4103/jehp.jehp_346_20

Year: 2020

What are Safety Committees?

How is Botulism Diagnosed?

Why are Confounding Variables Important?

Why are Academic Journals Important in Epidemiology?

How Do Epidemiology Consultants Work?

What Are the Benefits of CBS?

What is Hadoop?

What are the Side Effects of Ethambutol?

Why Is Geographic Location Important?

Why are Collaborative Projects Important?

Partnered Content Networks

Relevant Topics